Biocon Ltd.

View in App
240.40 -4.85 ▼-2.0%

02 June 2023, 04:01:00 PM
Volume: 236,108

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.biocon.com
Market Cap 28,862.42 Cr.
Enterprise Value(EV) 44,233.02 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 3.85 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 62.38 Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 148.82 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.62 Calculated using Price: 240.40
Dividend Yield 0.62 Period Ending 2022-03
No. of Shares Subscribed 120.06 Cr. 1,200,600,000 Shares
FaceValue 5
About Biocon Ltd.
The company is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as generic formulations in the US and Europe. It also has a pipeline of promising novel assets in immunotherapy under development.

Biocon Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Biocon Ltd. Performance

View details >>
1 Day
-1.98%
1 Week
+0.44%
1 Month
+0.65%
3 Month
+7.56%
6 Month
-15.26%
1 Year
-25.54%
2 Year
-38.06%
5 Year
-25.90%
10 Year
+433.16%

Biocon Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.68 17.22 16.91 15.74 9.17 18.01 14.26 12.03 9.83
Return on Capital Employed (%) 15.75 15.30 14.33 12.83 9.21 16.12 14.35 10.56 8.30
Return on Assets (%) 8.47 8.72 8.25 7.83 4.77 9.26 6.94 5.24 4.03

Biocon Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 3,027 3,271 4,034 4,838 5,181 6,098 6,706 7,627 8,433 17,867
Non Curr. Liab. 1,262 1,378 2,421 2,305 2,007 2,122 2,685 5,497 6,803 20,742
Curr. Liab. 1,380 1,555 1,666 1,678 2,141 3,039 4,008 4,170 3,828 8,511
Minority Int. 82 172 266 376 468 609 677 881 1,038 4,622
Equity & Liab. 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 51,742
Non Curr. Assets 3,112 3,813 4,416 5,149 5,648 6,979 8,751 10,614 11,718 39,408
Curr. Assets 2,639 2,563 3,971 4,048 4,149 4,889 5,325 7,548 8,382 12,334
Misc. Exp. not W/O
Total Assets 5,751 6,375 8,387 9,197 9,796 11,868 14,076 18,215 20,101 51,742

Biocon Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 2,877 3,090 3,347 3,891 4,123 5,514 6,301 7,143 8,184 11,174
Other Income 56 53 84 157 206 414 508 605 690 376
Total Income 2,933 3,143 3,431 4,048 4,330 5,929 6,808 7,748 8,874 11,550
Total Expenditure -2,190 -2,394 -2,584 -2,912 -3,294 -4,391 -5,044 -5,841 -6,691 -8,663
PBIDT 743 749 847 1,137 1,035 1,538 1,765 1,907 2,183 2,888
Interest -2 -9 -29 -26 -62 -71 -65 -58 -68 -419
Depreciation -204 -221 -249 -277 -385 -448 -552 -715 -814 -1,113
Taxation -107 -96 -142 -162 -157 -212 -315 -222 -212 -254
Exceptional Items 105 161 195 68 13 -111 -291
PAT 431 528 609 688 453 1,003 900 846 772 810
Minority Interest -17 -31 -59 -76 -81 -97 -123 -106 -123 -180
Share Associate -167
Other Related Items
Consolidated Net Profit 414 497 550 612 372 905 748 741 648 463
Adjusted EPS 3 4 5 5 3 8 6 6 5 4

Biocon Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 471 561 211 371 640 662 1,155 1,283 1,160 1,177
Cash Fr. Inv. -376 -938 -509 -1,142 -499 -684 -714 -1,559 -3,625 -1,699
Cash Fr. Finan. -9 426 186 1,068 -178 -240 -242 388 2,564 242
Net Change 87 49 -112 297 -36 -262 199 112 99 -280
Cash & Cash Eqvt 474 557 463 758 710 449 659 825 897 654

Biocon Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 60.67 60.64 60.64 60.64 60.64 60.64 60.64 60.64 60.64
Public 39.33 39.36 39.36 39.36 39.36 39.36 39.36 39.36 39.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Biocon Ltd. Announcements

View details >>
Fri, 02 Jun 2023
Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations 2015.
Meetings conducted with Institutional Investors/Research Analysts.
Wed, 31 May 2023
Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations 2015.
Meeting conducted with Institutional Investors/Research Analysts.
Wed, 31 May 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is further to our earlier letter dated May 24 2023 regarding presentation and video recording of Q4 and full year FY23 Earnings Call held on May 24 2023 please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/

Biocon Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High

Biocon Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 999.35 +1.2%
Divi's Laboratories Ltd. 93,340.08 3,539.90 +0.4%
Cipla Ltd. 77,917.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. 60,134.99 1,774.00 -0.1%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,539.90 +0.4%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 999.35 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,539.90 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%

Biocon Ltd. FAQ's

What is Biocon share price?
Can I buy Biocon shares now?
What is the Dividend Yield of Biocon?
What is the Market Cap of Biocon?
What are the key metrics to analyse Biocon?
What is the 52 Week High and Low of Biocon?
What is the trend of Biocon share price?